首页> 外文OA文献 >Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer

【2h】

Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer

机译：Sarcopenia和内脏肥胖不影响免疫检查点抑制剂单药治疗预处理患者的晚期非小细胞肺癌的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Seigo Minami; Shouichi Ihara; Tsunehiro Tanaka; Kiyoshi Komuta;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer [J] . Seigo Minami, Shouichi Ihara, Tsunehiro Tanaka, World Journal of Oncology . 2020,第1期

机译：Sarcopenia和内脏肥胖不影响免疫检查点抑制剂单药治疗预处理患者的晚期非小细胞肺癌的疗效
2. Differences in the efficacy of S-1 monotherapy according to histological type in pretreated patients with advanced non-small cell lung cancer [J] . HisamatsuY., MurakamiH., AkamatsuH., Thoracic cancer. . 2014,第2期

机译：根据组织学类型不同，S-1单一疗法在晚期非小细胞肺癌预治疗患者中的疗效差异
3. Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer [J] . Yamaguchi Ou, Imai Hisao, Minemura Hiroyuki, Cancer chemotherapy and pharmacology. . 2020,第4期

机译：免疫检查点抑制剂单疗法在预处理老年患者的非小细胞肺癌患者的疗效和安全性
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer [O] . Seigo Minami, Shouichi Ihara, Tsunehiro Tanaka, 2020

机译：肌肉减少症和内脏肥胖症不会影响免疫检查点抑制剂单药治疗晚期非小细胞肺癌患者的疗效。
7. Differences in the efficacy of S-1 monotherapy according to histological type in pretreated patients with advanced non-small cell lung cancer [O] . Yasushi Hisamatsu, Haruyasu Murakami, Hiroaki Akamatsu, 2014

机译：S-1单药治疗疗效的差异根据预处理患者的晚期非小细胞肺癌的组织学类型

Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅